Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Study ID: NCT07414953
Start Date: 2026-03-30
End Date: 2028-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

400

Intervention / Treatment

HS-10504

SHR-A2009

HS-20122

HS-20117

SHR-1826

SHR-A2102

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients

Study ID: NCT05279937
Start Date: 2026-06
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

40

Intervention / Treatment

Dextrose 50% Intravenous Solution

Lidocaine 1% Injectable Solution

Sponsor

Tulane University

Source: clinicaltrials.gov

Share:
Add to list

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Study ID: NCT07432568
Start Date: 2026-03-09
End Date: 2032-08-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Hepatic Arterial Infusion Chemotherapy (HAIC) with Liposomal Irinotecan, 5-Fluorouracil, Leucovorin

Lenvatinib

PD-1 Inhibitor

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Source: clinicaltrials.gov

Share:
Add to list

SII Levels Following PENG Block in Hip Arthroplasty

Study ID: NCT07449403
Start Date: 2026-04-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

sodium Chloride

Ropivacaine 0.2% Injectable Solution

Sponsor

Poznan University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Study ID: NCT07421297
Start Date: 2026-04-01
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

760

Intervention / Treatment

SYH2053injection

SYH2053 injection placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment

Study ID: NCT06809023
Start Date: 2026-04
End Date: 2029-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Sleep restriction

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Study ID: NCT07420959
Start Date: 2026-03-25
End Date: 2038-03-25
Study Type

Interventional

Study Phase

Phase2

No. of Participants

38

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Etentamig

Positron Emission Tomography

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance

Study ID: NCT07456462
Start Date: 2026-05-01
End Date: 2029-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

MRI assessment and blood sample collection

Sponsor

IRCCS San Raffaele

Source: clinicaltrials.gov

Share:
Add to list

Autologous Dentine Graft Compared to Xenograft in Managing Periodontally Compromised Second Molar After Third Molar Removal

Study ID: NCT07362394
Start Date: 2026-06-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Autologous dentin graft

Xenograft

Sponsor

National University of Malaysia

Source: clinicaltrials.gov

Share:
Add to list

HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics

Study ID: NCT07089966
Start Date: 2026-04-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30000

Intervention / Treatment

HTS counselor-led PrEP care model

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list